Role of plasma exchange in the thyroid storm

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 6, 2011, Pages 522-531

  Muller, Clotilde ^a   Perrin, Peggy ^a   Faller, Bernadette ^a   Richter, Sarah ^b   Chantrel, Francois ^a  

^a HÔPITAL CIVIL   (France)

^b Clinique Sainte Anne   (France)

Author keywords

Endocrinology; Plasma exchange; Thyroid storm

Indexed keywords

ANTIBODY; BISOPROLOL; CARBIMAZOLE; CORTICOSTEROID; CYTOKINE; POTASSIUM PERCHLORATE; PREDNISONE; PROPRANOLOL; THYROID HORMONE;

ADULT; AGED; ALLOPATHY; CASE REPORT; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; MALE; MEDICAL STAFF; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; THYROID CRISIS;

AGED; AGED, 80 AND OVER; ANTIBODIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; SEVERITY OF ILLNESS INDEX; THYROID CRISIS; THYROID HORMONES; TIME FACTORS; TREATMENT OUTCOME;

EID: 82155178417     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.01003.x     Document Type: Review

References (52)

1. Szczepiorkowski ZM, Bandarenko N, Kim HC etal. American society for apheresis: apheresis application committee of the American society for apheresis. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher 2007;22:106-75.
2. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993;22:263-77.
3. Ashkar PS, Katims RB, Smoak WM, Gilson AJ. Thyroid storm treatment with blood exchange and plasmapheresis. JAMA 1970;214:1275-9.
4. De Rosa G, Testa A, Menichella G etal. Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica 1991;76(Suppl 1):72-4.
5. Boers PM, Colebatch JG. Hashimoto's encephalopathy responding to plasmapheresis. J Neurol Neurosurg Psychiatry 2001;70:132-41.
6. Adali E, Yildizhan R, Kolusari A. The use of plasmapheresis for rapid hormonal control in severe hyperthyroidism caused by a partial molar pregnancy. Arch Gynecol Obstet 2009;279:569-71.
7. Dandona P, Marshall NJ, Bidey SP, Nathan A, Havard CW. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1979;1:374-6.
8. Sawers JS, Irvine WJ, Toft AD, Urbaniak SJ, Donaldson AA. Plasma exchange in conjunction with immunosuppressive drug therapy in the treatment of endocrine exophthalmos. J Clin Lab Immunol 1981;6:245-50.
9. Yamamoto K, Saito K, Takai T, Yoshida S. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement. Endocrinol Jpn 1982;29:495-501.
10. Kuzuya N, Degroot LJ. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema. J Endocrinol Invest 1982;5:373-8.
11. Glinoer D, Schrooyen M. Plasma exchange therapy for severe Graves' ophthalmopathy. Horm Res 1987;26:184-9.
12. Glinoer D, Etienne-Decerf J, Schrooyen M etal. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Metab Pediatr Syst Ophthalmol 1988;11:133-40.
13. Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1997;11:521-36.
14. Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher. 2009;24(3):111-4.
15. Herrmann J, Hilger P, Kruskemper HL. Plasmapheresis in the treatment of thyrotoxic crisis (measurement of half-concentration times for free and total T3 and T4). Acta Endocrinol Suppl (Copenh) 1973;173:22.
16. Horn K, Brehm G, Habermann J, Pickardt CR, Scriba PC. Successful treatment of thyroid storm by continuous plasmapheresis with a blood-cell separator (author's transl). Klin Wochenschr 1976;54:983-6.
17. Gabry AL, Hugon S, Rathat C, Le Floch A, Cupa M. Thyrotoxicosis. Quick preparation to thyroidectomy by plasmapheresis (author's transl). Anesth Analg (Paris) 1981;38:711-2.
18. Martin C, Auffray JP, Rocca B, Dumas D, Gouin F. Post-operative thyroid storm treated by plasmapheresis (author's transl) Anesth Analg (Paris) 1981;38:713-5.
19. Ogriseg M, Fill H, Kirchmair W, Stuhlinger W. Plasma filtration treatment in thyreotoxic crisis. Schweiz Med Wochenschr 1981;111:592-6.
20. Van de Vyver F, Verpooten GA, DeBroe ME, Bleys W, Bekaert J, Abs R. Plasmafiltration in factitious hyperthyroidism. Artif Organs 1982;6:230.
21. nd symposium on therapeutic plasmapheresis. Tokyo 1982;559-60.
22. May ME, Mintz PD, Lowry P, Geller R, Curnow RT. Plasmapheresis in thyroxine overdose: a case report. J Toxicol Clin Toxicol 1983;20:517-20.
23. Patte D, Läger FA, Savoie JC etal. Thyrotoxicosis, then hypothyroidism caused by iodine overload associated with neuropathy. Failure of plasma exchange. Ann Med Interne (Paris) 1983;134:31-4.
24. Newcomer J, Haire W, Hartman CR. Coma and thyrotoxicosis. Ann Neurol 1983;14:689-90.
25. Tajiri J, Katsuya H, Kiyokawa T, Urata K, Okamoto K, Shimada T. Successful treatment of thyrotoxic crisis with plasma exchange. Crit Care Med 1984;12:536-7.
26. Sprenger KB, Kratz W, Huber K, Franz HE. 2-pool model of thyroid hormones for plasma exchange therapy. Life Support Syst 1985;3:44-50.
27. Schlienger JL, Faradji A, Sapin R etal. Treatment of severe hyperthyroidism by plasma exchange. Clinical and biological efficacy. 8 cases. Presse Med 1985;14:1271-4.
28. Braithwaite SS, Brooks MH, Collins S, Bermes EW. Plasmapheresis: an adjunct to medical management of severe hyperthyroidism. J Clin Apher 1986;3:119-23.
29. Geissler D, Ogriseg M, Fill H, Wolf H. Plasmapheresis treatment in 3 simultaneously occurring autoimmune diseases: Hashimoto thyroiditis with hyperthyroidism, autoimmune thrombopenia and autoimmune hemolytic anemia. Wien Klin Wochenschr 1987;99:351-5.
30. Binimelis J, Bassas L, Marruecos L etal. Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 1987;13:33-8.
31. Segers O, Spapen H, Steenssens L, Cytryn R, Jonckheer MH, Vanhaelst L. Treatment of severe iodine-induced hyperthyroidism with plasmapheresis. Acta Clin Belg 1988;43:335-43.
32. Uzzan B, Pussard E, Leon A etal. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol 1991;31:371-2.
33. Puy H, Lamoryl J, Marcelli JM, Lalau JD, Debussche X, Quichaud J. Thyroid hormone extraction by plasma exchange. A study of extraction rate. Biomed Pharmacother 1992;46:413-17.
34. Schlienger JL, Sapin R, Faradji A. Plasmapheresis induces high reverse T3 levels in euthyroid and hyperthyroid patients. Horm Metab Res 1992;24:46-7.
35. Aghini-Lombardi F, Mariotti S, Fosella PV etal. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 1993;16:823-6.
36. Henderson A, Hickman P, Ward G, Pond SM. Lack of efficacy of plasmapheresis in a patient overdosed with thyroxine. Anaesth Intensive Care 1994;22:463-4.
37. Samaras K, Marel GM. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis. Clin Endocrinol 1996;45:365-8.
38. Ligtenberg J, Tulleken J, Zijlstra J. Plasmapheresis in thyrotoxicosis. Ann Intern Med 1999;131:71-2.
39. Nieuwenhuis L, Santens P, Vanwalleghem P, Boon P. Subacute Hashimoto's encephalopathy, treated with plasmapheresis. Acta Neurol Belg 2004;104:80-3.
40. Diamond TH, Rajagopal R, Ganda K, Manoharan A, Luk A. Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Intern Med J 2004;34:369-70.
41. Kokuho T, Kuji T, Yasuda G. Thyroid storm-induced multiple orange failure relieved quickly by plasma exchange therapy. Ther Apher Dial 2004;8:347-9.
42. Ozbey N, Kalayoglu-Besisik S, Gul N, Bozbora A, Sencer E, Molvalilar S. Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated. Int J Clin Pract 2004;58:554-8.
43. Guvenc B, Unsal C, Gurkan E, Dincer S. Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report. J Clin Apher 2004;19:148-50.
44. Erbil Y, Tihan D, Azezli A etal. Severe hyperthyroidism requiring therapeutic plasmapheresis in a patient with hydatidiform mole. Gynecol Endocrinol 2006;22:402-4.
45. Azezli A, Bayraktaroglu T, Topuz S, Kalayoglu-Besisik S. Hyperthyroidism in molar pregnancy: rapid preoperative preparation by plasmapheresis and complete improvement after evacuation. Transfus Apher Sci 2007;36:87-89.
46. Pasimeni G, Caroli F, Spriano G, Antonini M, Baldelli R, Appetecchia M. Refractory thyrotoxicosis induced by iodinated contrast agents treated with therapeutic plasma exchange. A case report. J Clin Apher 2008;23:92-5.
47. Glinoer D, Gaham N, Sand G etal. Use of plasmapheresis in a case of Graves' disease with malignant ophthalmopathy (author's transl). Ann Endocrinol (Paris) 1981;42:545-6.
48. De Rosa G, Corsello SM, Della Casa S etal. Plasma exchange in the treatment of established chronic exophtalmos. Curr Ther Res 1982;31:944.
49. Pimentel L, Hansen KN. Thyroid disease in the emergency department: a clinical and laboratory review. J Emerg Med 2004;28:201-9.
50. Pinsard D, Chadenas D, Pierre D, Walle T, Aumaitre J. Plasma exchange and hyperthyroidism. Current indications. Ann Endocrinol (Paris) 1985;46:89-98.
51. Szczepiorkowski ZM, Winters JL, Bandarenko N etal. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
52. McLeod BC, Sniecinski I, Ciavarella D etal. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999;39:282-8.